Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

INSMED Inc Director's Dealing 2024

May 15, 2024

30150_dirs_2024-05-15_5eb2cfa1-a354-47ce-b9f6-e658abf4128b.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: INSMED Inc (INSM)
CIK: 0001104506
Period of Report: 2024-05-13

Reporting Person: Lewis William (Director, Chair and CEO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2024-05-13 Common Stock A 42707 Acquired 406323 Direct
2024-05-14 Common Stock S 22198 $25.52 Disposed 384125 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2024-05-13 Stock Option (right to buy) $25.83 A 209320 Acquired 2034-05-13 Common Stock (209320) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 233924 Indirect
Common Stock 50500 Indirect

Footnotes

F1: Represents Restricted Stock Units (RSUs), each representing a contingent right to receive one share of Common Stock, granted pursuant to the Company's Amended and Restated 2019 Incentive Plan, as amended. The RSUs vest as follows: 25% percent on the first day of the first month following the first anniversary of the date of grant (the Initial Vesting Date) and 25% on each anniversary of the Initial Vesting Date until fully vested.

F2: Each RSU was granted on May 13, 2024 for no consideration.

F3: Shares sold to satisfy withholding tax obligations upon the vesting of RSUs and to cover related broker fees.

F4: This is the weighted average sales price representing 22,198 shares sold at prices ranging from $25.41 to $25.67 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

F5: These stock options were granted under the Company's Amended and Restated 2019 Incentive Plan, as amended. The options become exercisable based on the following vesting schedule: 25% vest on the Initial Vesting Date and an additional 12.5% vest every six months thereafter through the fourth anniversary of the Initial Vesting Date.